Are hematoma size and treatment timing associated with outcome in aneurysmal intracerebral hemorrhage? A systematic review of published case reports and case series
This systematic review of aneurysmal intracerebral hemorrhage cases indicates that while small hematoma size is strongly associated with favorable neurological outcomes, the relationship between treatment timing and outcome is complex and likely confounded by selection bias rather than demonstrating a clear benefit for delayed intervention.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
When a brain aneurysm bursts, it is a catastrophic event where a weak spot in a blood vessel gives way, flooding the surrounding tissue with blood. While these ruptures often spill blood into the fluid-filled spaces around the brain, sometimes the blood punches directly into the brain tissue itself, creating a bruise known as a hematoma. This internal bleeding is particularly dangerous because it acts like a swelling mass, pressing against the delicate structures of the brain, raising pressure, and potentially causing immediate damage or death. Doctors have long debated how best to manage this specific type of injury. The core of the dilemma involves three critical questions: does the size of the blood clot matter most, does the patient's condition when they arrive at the hospital dictate their fate, and is there a specific window of time after the rupture where surgery offers the best chance for survival?
To find answers, a team of researchers from the University of Nis in Serbia conducted a massive review of existing medical literature. They did not treat new patients themselves; instead, they gathered and analyzed data from nearly 10,000 published reports, eventually narrowing their focus to 93 studies that contained detailed information on 2,524 patients. These studies ranged from individual case reports of single patients to larger case series tracking hundreds of people. The researchers sorted this data into two main groups based on the size of the brain bleed: those with small hematomas and those with large ones. They then looked closely at how these patients were treated, whether the doctors operated within the first day, waited a few days, or delayed further, and what the final health outcomes were for each person.
The review revealed a clear and stark divide based on the size of the injury. Patients with small hematomas generally arrived at the hospital in much better condition and had significantly higher rates of recovery. In the group of individual case reports, about 61 percent of those with small bleeds achieved a good neurological outcome, compared to only 20 percent of those with large bleeds. The size of the clot also dictated the type of surgery performed. When the bleed was large, doctors almost always chose open microsurgery, where they physically cut into the skull to remove the blood and clip the aneurysm. This approach was used in nearly 80 percent of the large-bleed cases. In contrast, patients with smaller bleeds received a more even mix of open surgery and less invasive endovascular treatments, which involve threading a catheter through blood vessels to seal the aneurysm from the inside.
The question of timing, however, proved to be far more complex and less definitive than the size of the clot. For the patients described in individual case reports, the researchers found that operating early, within the first 24 hours, did not statistically guarantee a better outcome compared to waiting, once the patient's initial condition was taken into account. The story changed slightly when looking at the larger group of patients from the case series. In this larger dataset, those who received treatment between 24 and 72 hours after the rupture appeared to have better outcomes than those treated immediately. However, the researchers were careful to explain that this finding likely does not mean waiting is actually better. Instead, it suggests that patients who were stable enough to wait for a few days were already in better shape than those who were rushed to the operating room in a critical state. The data showed that patients treated very early often had the most severe symptoms to begin with, which skewed the results.
Ultimately, the study suggests that the patient's condition at the moment of treatment is a stronger predictor of success than the speed of the surgery itself. A significant number of patients who arrived at the hospital in good condition still suffered poor outcomes, likely due to secondary complications like brain swelling or re-bleeding that occurred after the initial event. The researchers concluded that while small bleeds generally lead to better recoveries and large bleeds usually require aggressive open surgery, there is no single, universal rule that says "sooner is always better." The decision on when to operate appears to depend heavily on the specific clinical picture of the patient, and the apparent advantage of waiting a few days in some groups was likely a reflection of their initial stability rather than the benefits of the delay itself.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.